A. Real time PCR analyses of miR-375 (left panel) and miR-301a (right panel) in CRPC-NE (LuCaP 49, 145.1 and 145.2) vs CRPC-Adeno PDX models (LuCaP 70, 78, 81 and 92). RNU48 was used an endogenous control.
B. Real time PCR analyses of miR-375 (left panel) and miR-301a (right panel) in BPH1 and PCa cell lines (PC3, LNCaP, LNCaP-AR, LNCaP-AR-Enzalutamide resistant, NCI-H660). RNU48 was used as an endogenous control.
C. LNCaP and C42B cells were transinetly transfected with control/miR-375/miR-301a mimics for 72 hours followed by functional assays. Real time PCR analyses of miR-375 and miR-301a expression in control/miR-375 transfected or control/miR-301a transfected LNCaP and C42B cells. RNU48 was used an endogenous control.
D. In vitro migration (left panels) and invasion assays (right panels) in control/miR-375 (upper panels) and control/miR-301a-transfected (lower panels) LNCaP and C42B cells.
E. Left panel: Real time PCR analyses of ENO2 and SYP expression in miR-CON/miR-375 transfected LNCaP and C42B cells. GAPDH was used as an endogenous control. Right panel: Western blot analyses of CHGA and ENO2 in miR-CON/miR-375 transfected LNCaP and C42B cells. GAPDH was used as a loading control.
F. Western blot analyses of Akt and Src in miR-CON/miR-375 transfected LNCaP and C42B cells. GAPDH was used as a loading control.
G. Real time PCR analyses of ENO2 and AR expression in miR-CON/miR-301a transfected LNCaP and C42B cells. GAPDH was used as an endogenous control.
H. Western blot analyses of CHGA, ENO2 and AR in miR-CON/miR-301a transfected LNCaP and C42B cells. GAPDH was used as a loading control.